Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy

ClinicalTrials.gov ID: NCT03304522

Public ClinicalTrials.gov record NCT03304522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 11:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled, 6-Week, Parallel-design Study of the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy

Study identification

NCT ID
NCT03304522
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vertex Pharmaceuticals Incorporated
Industry
Enrollment
89 participants

Conditions and interventions

Interventions

  • VX-150 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 19, 2017
Primary completion
Oct 11, 2018
Completion
Nov 7, 2018
Last update posted
Nov 14, 2021

2017 – 2018

United States locations

U.S. sites
31
U.S. states
19
U.S. cities
29
Facility City State ZIP Site status
Xenoscience Inc. - 21st Century Neurology Phoenix Arizona 85004
Phoenix Neurological Associates, Ltd. Phoenix Arizona 85251
Sutter Health - Alta Bates Summit Medical Center - The Jordan Research & Education Institute Berkeley California 94705
Neuropain Medical Center Fresno California 93710
University of California San Diego La Jolla California 92093
SDS Clinical Trials, Inc. Orange California 92868
Stanford University School of Medicine Redwood City California 94063
Blue Sky Neurology Englewood Colorado 80113
Bioclinica Research - Orlando Orlando Florida 32806
Infinity Clinical Research Sunrise Florida 33351
Southern Illinois University (SIU) School of Medicine Springfield Illinois 62702
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Kansas Medical Center (KUMC) Kansas City Kansas 66160
International Clinical Research Institute (ICRI) Overland Park Kansas 66210
River Cities Clinical Research Center Shreveport Louisiana 71105
The Johns Hopkins Hospital Baltimore Maryland 21287
Washington University School of Medicine in St. Louis St Louis Missouri 63110
Dartmouth-Hitchcock Medical Center (DHMC) Lebanon New Hampshire 03756
Robert Wood Johnson Medical School New Brunswick New Jersey 08901
University of New Mexico Hospital Albuquerque New Mexico 87131
Albany Medical Center- Neurology Group Albany New York 12208
The Mount Sinai Hospital New York New York 10029
Columbia University Medical Center New York New York 10032
University of Rochester Rochester New York 14618
University of North Carolina School of Medicine Chapel Hill North Carolina 27514
Duke Neurological Disorders Clinic Durham North Carolina 27710
Carolinas Pain Institute Winston-Salem North Carolina 27103
Neurology Diagnostics, Inc Dayton Ohio 45459
The Richter Clinic for Neurology and Neuro-Psychiatry Tulsa Oklahoma 74104
Carilion Clinic Neurology Roanoke Virginia 24013
University of Washington Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03304522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2021 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03304522 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →